On-demand webinar: COPD and cardiovascular risk: The deadly duo

CPD hours: Educational activities: 
1.5
CPD hours: Measuring outcomes: 
0
CPD hours: Reviewing performance: 
0

You need to login to participate in this education.

Please log in, or if you don't already have a free account, register to continue.

This education is accredited: RACGP 1.5 CPD, ACRRM 1.5 CME PD.

Presented by GP Conjoint A/Prof Chee Khoo and Conjoint A/Prof Belinda Cochrane, this webinar explores the link between COPD and CV risk, reviews latest recommendations for COPD management, and describes the actions you can take to reduce the risk of exacerbations in patients with COPD.

On completion of this education activity participants will be able to:

    • Diagnose COPD using current Australian guidelines.
    • Discuss how morbidity and mortality risk are substantially heightened following an acute COPD exacerbation, with increased risk of a cardiovascular events.
    • Develop strategies for recognising and reducing the incidence of exacerbations in COPD.
    • Develop strategies to screen for other associated co-morbidities in patients with COPD.
    • Implement an effective and comprehensive management plan for patients with COPD.

     

 

Presented by Conjoint A/Prof Chee Khoo and Conjoint A/Prof Belinda Cochrane

Conjoint Associate Professor Chee Khoo M.B.,B.S. Hons.

An educator with a special interest in chronic disease, Conjoint A/Prof Khoo has been a practicing solo GP in Ingleburn since 1990. He is the Chair of the Education Working Group at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU). He is a member of the RACGP’s Specific Interest Groups in Diabetes and Obesity Management and the Editor-in-chief at GPVoice.com.au

Conjoint Associate Professor Belinda Cochrane

Conjoint A/Prof Belinda Cochrane is a Respiratory & Sleep Medicine Staff Specialist at Camden and Campbelltown Hospitals in Sydney. She is an SME reviewer for the COPD-X Guidelines Committee for cardiology related respiratory papers, and a member of the Statewide Respiratory Network in New South Wales. Her research interests include COPD and its relationship with cardiac disease, breathlessness and inhaler device capability.

This session is sponsored by AstraZeneca.

This webinar has been has been approved as a Lung Learning Quality-Assured Activity. It can be viewed at https://www.lunglearninghub.com.au

References:

  1. Zhou Y et al. Int J Chron Obstruct Pulmon Dis. 2023;18:2839-47
  2. Yang IA et al. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2023. Version 2.72, October 2023
  3. Reilev M et al. Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD. Respirology. 2019 Dec;24(12):1183-1190.
Sponsored by: 
Components
On-demand webinar: COPD and cardiovascular risk: The deadly duo - Education
On-demand webinar: COPD and cardiovascular risk: The deadly duo - Evaluation